Moving the Needle Cautiously in Targeting One of the Most Often Acquired Receptor Tyrosine Fusion (RET Fusion) Resistance Mechanisms to EGFR Tyrosine Kinase Inhibitors

被引：0
作者：
Zhang, Shannon S. [1 ]
Ou, Sai-Hong Ignatius [1 ,2 ,3 ,4 ]
机构：
[1] Univ Calif Irvine, Dept Med, Sch Med, Orange, CA USA
[2] Chao Family Comprehens Canc Ctr, Orange, CA USA
[3] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Dept Med, Sch Med, 200 South Manchester Ave,Suite 400, Orange, CA 92868 USA
[4] Univ Calif Irvine, Sch Med, Dept Med, Div Hematol & Oncol, 200 South Manchester Ave,Suite 400, Orange, CA 92868 USA
来源：
JTO CLINICAL AND RESEARCH REPORTS | 2022年 / 3卷 / 08期
关键词：
LUNG-CANCER; ALK;
D O I：
10.1016/j.jtocrr.2022.100358
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 14 条
  • [1] Acquired Resistance to KRASG12C Inhibition in Cancer
    Awad, M. M.
    Liu, S.
    Rybkin, I. I.
    Arbour, K. C.
    Dilly, J.
    Zhu, V. W.
    Johnson, M. L.
    Heist, R. S.
    Patil, T.
    Riely, G. J.
    Jacobson, J. O.
    Yang, X.
    Persky, N. S.
    Root, D. E.
    Lowder, K. E.
    Feng, H.
    Zhang, S. S.
    Haigis, K. M.
    Hung, Y. P.
    Sholl, L. M.
    Wolpin, B. M.
    Wiese, J.
    Christiansen, J.
    Lee, J.
    Schrock, A. B.
    Lim, L. P.
    Garg, K.
    Li, M.
    Engstrom, L. D.
    Waters, L.
    Lawson, J. D.
    Olson, P.
    Lito, P.
    Ou, S. -H. I.
    Christensen, J. G.
    Janne, P. A.
    Aguirre, A. J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (25) : 2382 - 2393
  • [2] FDA Approval Summary: Selpercatinib for the Treatment of Lung and Thyroid Cancers with RET Gene Mutations or Fusions
    Bradford, Diana
    Larkins, Erin
    Mushti, Sirisha L.
    Rodriguez, Lisa
    Skinner, Amy M.
    Helms, Whitney S.
    Price, Lauren S. L.
    Zirkelbach, Jeanne Fourie
    Li, Yangbing
    Liu, Jiang
    Charlab, Rosane
    Turcu, Francisca Reyes
    Liang, Dun
    Ghosh, Soma
    Roscoe, Donna
    Philip, Reena
    Zack-Taylor, Autumn
    Tang, Shenghui
    Kluetz, Paul G.
    Beaver, Julia A.
    Pazdur, Richard
    Theoret, Marc R.
    Singh, Harpreet
    [J]. CLINICAL CANCER RESEARCH, 2021, 27 (08) : 2130 - 2135
  • [3] Food and Drug Administration, Highlights of prescribing information: GavretoTM
  • [4] A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing
    Ju, Young Seok
    Lee, Won-Chul
    Shin, Jong-Yeon
    Lee, Seungbok
    Bleazard, Thomas
    Won, Jae-Kyung
    Kim, Young Tae
    Kim, Jong-Il
    Kang, Jin-Hyoung
    Seo, Jeong-Sun
    [J]. GENOME RESEARCH, 2012, 22 (03) : 436 - 445
  • [5] Kim J, 2021, CLIN CANCER RES, V27, P5452, DOI [DOI 10.1158/1078-0432.CCR-21-0967, 10.1158/1078-0432.CCR-21-0967]
  • [6] KIF5B-RET fusions in lung adenocarcinoma
    Kohno, Takashi
    Ichikawa, Hitoshi
    Totoki, Yasushi
    Yasuda, Kazuki
    Hiramoto, Masaki
    Nammo, Takao
    Sakamoto, Hiromi
    Tsuta, Koji
    Furuta, Koh
    Shimada, Yoko
    Iwakawa, Reika
    Ogiwara, Hideaki
    Oike, Takahiro
    Enari, Masato
    Schetter, Aaron J.
    Okayama, Hirokazu
    Haugen, Aage
    Skaug, Vidar
    Chiku, Suenori
    Yamanaka, Itaru
    Arai, Yasuhito
    Watanabe, Shun-ichi
    Sekine, Ikuo
    Ogawa, Seishi
    Harris, Curtis C.
    Tsuda, Hitoshi
    Yoshida, Teruhiko
    Yokota, Jun
    Shibata, Tatsuhiro
    [J]. NATURE MEDICINE, 2012, 18 (03) : 375 - 377
  • [7] Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies
    Lipson, Doron
    Capelletti, Marzia
    Yelensky, Roman
    Otto, Geoff
    Parker, Alex
    Jarosz, Mirna
    Curran, John A.
    Balasubramanian, Sohail
    Bloom, Troy
    Brennan, Kristina W.
    Donahue, Amy
    Downing, Sean R.
    Frampton, Garrett M.
    Garcia, Lazaro
    Juhn, Frank
    Mitchell, Kathy C.
    White, Emily
    White, Jared
    Zwirko, Zac
    Peretz, Tamar
    Nechushtan, Hovav
    Soussan-Gutman, Lior
    Kim, Jhingook
    Sasaki, Hidefumi
    Kim, Hyeong Ryul
    Park, Seung-il
    Ercan, Dalia
    Sheehan, Christine E.
    Ross, Jeffrey S.
    Cronin, Maureen T.
    Jaenne, Pasi A.
    Stephens, Philip J.
    [J]. NATURE MEDICINE, 2012, 18 (03) : 382 - 384
  • [8] Midha A, 2015, AM J CANCER RES, V5, P2892
  • [9] Landscape of Acquired Resistance to Osimertinib in EGFR-Mutant NSCLC and Clinical Validation of Combined EGFR and RET Inhibition with Osimertinib and BLU-667 for Acquired RET Fusion
    Piotrowska, Zofia
    Isozaki, Hideko
    Lennerz, Jochen K.
    Gainor, Justin F.
    Lennes, Inga T.
    Zhu, Viola W.
    Marcoux, Nicolas
    Banwait, Mandeep K.
    Digumarthy, Subba R.
    Su, Wenjia
    Yoda, Satoshi
    Riley, Amanda K.
    Nangia, Varuna
    Lin, Jessica J.
    Nagy, Rebecca J.
    Lanman, Richard B.
    Dias-Santagata, Dora
    Mino-Kenudson, Mari
    Iafrate, A. John
    Heist, Rebecca S.
    Shaw, Alice T.
    Evans, Erica K.
    Clifford, Corinne
    Ou, Sai-Hong, I
    Wolf, Beni
    Hata, Aaron N.
    Sequist, Lecia, V
    [J]. CANCER DISCOVERY, 2018, 8 (12) : 1529 - 1539
  • [10] Overcoming MET-Dependent Resistance to Selective RET Inhibition in Patients with RET Fusion-Positive Lung Cancer by Combining Selpercatinib with Crizotinib
    Rosen, Ezra Y.
    Johnson, Melissa L.
    Clifford, Sarah E.
    Somwar, Romel
    Kherani, Jennifer F.
    Son, Jieun
    Bertram, Arrien A.
    Davare, Monika A.
    Gladstone, Eric
    Ivanova, Elena, V
    Henry, Dahlia N.
    Kelley, Elaine M.
    Lin, Mika
    Milan, Marina S. D.
    Nair, Binoj C.
    Olek, Elizabeth A.
    Scanlon, Jenna E.
    Vojnic, Morana
    Ebata, Kevin
    Hechtman, Jaclyn F.
    Li, Bob T.
    Sholl, Lynette M.
    Taylor, Barry S.
    Ladanyi, Marc
    Janne, Pasi A.
    Rothenberg, S. Michael
    Drilon, Alexander
    Oxnard, Geoffrey R.
    [J]. CLINICAL CANCER RESEARCH, 2021, 27 (01) : 34 - 42
12